Next Article in Journal
Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-c]pyridine Derivatives as Hsp90 Inhibitors
Previous Article in Journal
Impact of Genetic Variants on Pregabalin Pharmacokinetics and Safety
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 18
Issue 2
10.3390/ph18020152
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Pharmaceuticals 2022, 15(6), 732.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732

by
Jerzy Maksymowicz
1,
Anna Palko-Łabuz
1,
Beata Sobieszczańska
2,
Mateusz Chmielarz
1,2,
Mirosława Ferens-Sieczkowska
3,
Magdalena Skonieczna
4,5,
Agnieszka Wikiera
6,
Olga Wesołowska
1,*,† and
Kamila Środa-Pomianek
1,*,†
1
Department of Biophysics and Neuroscience, Wroclaw Medical University, 50-367 Wroclaw, Poland
2
Department of Microbiology, Wroclaw Medical University, 50-367 Wrocław, Poland
3
Department of Chemistry and Immunochemistry, Wroclaw Medical University, 50-367 Wroclaw, Poland
4
Department of Systems Biology and Engineering, The Silesian University of Technology, 44-100 Gliwice, Poland
5
Biotechnology Centre, Silesian University of Technology, 44-100 Gliwice, Poland
6
Department of Biotechnology and General Technology of Foods, Faculty of Food Technology, University of Agriculture in Krakow, 31-120 Krakow, Poland
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Pharmaceuticals 2025, 18(2), 152; https://doi.org/10.3390/ph18020152
Submission received: 16 December 2024 / Revised: 27 December 2024 / Accepted: 1 January 2025 / Published: 24 January 2025
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 10 as published. By mistake, we doubled panels B2–B4 and presented them as panels C2–C4 which of course should not be identical to panel B. This error was not intentional; however, we realized that it may lead to confusion among readers. The corrected Figure 10 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Maksymowicz, J.; Palko-Łabuz, A.; Sobieszczańska, B.; Chmielarz, M.; Ferens-Sieczkowska, M.; Skonieczna, M.; Wikiera, A.; Wesołowska, O.; Środa-Pomianek, K. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732. [Google Scholar] [CrossRef] [PubMed]
Pharmaceuticals 18 00152 g001
Figure 10. Adherence of the E. coli LF82 strain to HCT 116 cells (A) in the presence of pectins during a 2 h incubation period. The means of three experiments ± SD are presented. Statistical significance (* p < 0.05) was assessed between the experimental groups and controls (no pectin), which were assumed to be 100%. Representative images of bacteria adhering to untreated HCT 116 cells (B1,C1) and cells treated with PX (B) or PCX (C) at concentrations of 0.125 mg/mL (B2,C2), 0.25 mg/mL (B3,C3), and 0.5 mg/mL (B4,C4). Wright–Giemsa stain, 100× magnification.
Figure 10. Adherence of the E. coli LF82 strain to HCT 116 cells (A) in the presence of pectins during a 2 h incubation period. The means of three experiments ± SD are presented. Statistical significance (* p < 0.05) was assessed between the experimental groups and controls (no pectin), which were assumed to be 100%. Representative images of bacteria adhering to untreated HCT 116 cells (B1,C1) and cells treated with PX (B) or PCX (C) at concentrations of 0.125 mg/mL (B2,C2), 0.25 mg/mL (B3,C3), and 0.5 mg/mL (B4,C4). Wright–Giemsa stain, 100× magnification.
Pharmaceuticals 18 00152 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Maksymowicz, J.; Palko-Łabuz, A.; Sobieszczańska, B.; Chmielarz, M.; Ferens-Sieczkowska, M.; Skonieczna, M.; Wikiera, A.; Wesołowska, O.; Środa-Pomianek, K. Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732. Pharmaceuticals 2025, 18, 152. https://doi.org/10.3390/ph18020152

AMA Style

Maksymowicz J, Palko-Łabuz A, Sobieszczańska B, Chmielarz M, Ferens-Sieczkowska M, Skonieczna M, Wikiera A, Wesołowska O, Środa-Pomianek K. Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732. Pharmaceuticals. 2025; 18(2):152. https://doi.org/10.3390/ph18020152

Chicago/Turabian Style

Maksymowicz, Jerzy, Anna Palko-Łabuz, Beata Sobieszczańska, Mateusz Chmielarz, Mirosława Ferens-Sieczkowska, Magdalena Skonieczna, Agnieszka Wikiera, Olga Wesołowska, and Kamila Środa-Pomianek. 2025. "Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732" Pharmaceuticals 18, no. 2: 152. https://doi.org/10.3390/ph18020152

APA Style

Maksymowicz, J., Palko-Łabuz, A., Sobieszczańska, B., Chmielarz, M., Ferens-Sieczkowska, M., Skonieczna, M., Wikiera, A., Wesołowska, O., & Środa-Pomianek, K. (2025). Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732. Pharmaceuticals, 18(2), 152. https://doi.org/10.3390/ph18020152

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop